Delivery Order SPE2DR25D2002-SPE2DR26FBTF7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for Adderall XR 10 mg capsules (100-count units) with a ceiling value of $2,898.94. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,290.28 to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) on January 6, 2026, with an ultimate completion date of January 7, 2026. This contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,592.02 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100 count) on January 13, 2026, with an ultimate completion date of January 14, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's parent...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 9, 2026, for the supply of Adderall XR 30 mg capsules (100-count units) with a ceiling value of $1,102.21. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion by January 12, 2026, with performance taking place at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,105.08 to AmerisourceBergen Drug Corp for Adderall XR 30 mg capsules (100 count) on December 3, 2025, with completion due by December 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) valued at $2,051.22. This is a firm fixed-price delivery order with an ultimate completion date of January 2, 2026, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Adderall XR 30 mg capsules (100 count) with a ceiling value of $1,704.60. This firm fixed price contract, with an ultimate completion date of November 5, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at approximately $1 billion through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Adderall XR 30 mg capsules (100-count units) with a contract ceiling value of $2,078.26. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. The contract was executed under AmerisourceBergen Drug Corp's subsidiary status, with Cencora, Inc. serving as the parent organization. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 12, 2026, for the supply of Adderall XR 30 mg capsules (100-count packages) with a ceiling value of $1,098.28. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. The ultimate completion date is January 13, 2026, and performance will take place at the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) valued at $2,872.94. This is a firm fixed-price delivery order with an ultimate completion date of December 16, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- SPE2DR25D2002Indefinite Delivery Contract
- SPE2DR25D2002-SPE2DR26FBTF7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,810.64 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Adderall XR 30 mg capsules (100-count units). The order represents a non-set-aside, competitively awarded contract with firm fixed pricing and is scheduled for completion by January 14, 2026. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for pharmaceutical supply to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military treatment facilities globally. The parent company, Cencora, holds the primary $999,999,999.00 IDC with DLA through December 31, 2031, enabling comprehensive delivery of specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for Adderall XR reflects the contractor's ongoing role in supplying controlled pharmaceutical substances to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 1/12/26 |